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The structure of linkers affects the DNA binding properties of tethered dinuclear 
ruthenium (II) metallo-intercalators 
Hiwa K Saeed[a], Ibrahim Q Saeed[b], Niklaas J Buurma[b], and Jim A. Thomas*[a] 
Dedication ((optional)) 
Abstract: With the long-term aim of 
enhancing the binding properties of 
dinuclear RuII-based DNA light-switch 
complexes, a series of eight structurally 
related mono- and dinuclear systems 
are reported in which the linker of the 
bridging ligand has been modulated. 
These tethered systems have been 
designed to explore issues of steric 
demand at the binding site and the 
thermodynamic cost of entropy loss 
upon binding. An analysis of detailed 
spectroscopic and isothermal titration 
calorimetry (ITC) studies on the new 
complexes reveal that one of the linkers 
produces a dinuclear systems that binds 
to duplex DNA with an affinity (Kb > 
107 M-1) that is higher than its 
corresponding monometallic complex 
and is the highest affinity for a non-
threading bis-intercalating metal 
complex. These studies confirm that the 
tether has a major effect on the binding 
properties of dinuclear complexes 
containing nintercalating units and 
establishes key design rules for the 
construction of dinuclear complexes 
with enhanced DNA binding 
characteristics. 
Keywords: Ruthenium • DNA • 
luminescence • ITC • intercalation 
 
Introduction 
The interactions of metal complexes with biomolecules are 
attracting increasing attention. [1-10] In this context, the DNA binding 
properties of [Ru(phen)2(dppz)]2+ (1) (phen = 1,10-phenanthroline, 
dppz = dipyrido[3,2-a:2,3-c]phenazine) – Fig 1 - are of particular 
interest. [11-13] Although it was long accepted that intercalation of the 
dppz ligand between base pairs forms the basis of interaction 
between the complex and duplex DNA, the exact orientation of the 
DNA bound complex has been much discussed. [14-20] Recently, a 
series of X-ray crystallography studies on 1 and analogues have 
confirmed that intercalation of the dppz moiety occurs with the 
complex in the minor groove, but also revealed that binding is 
modulated by ancillary ligands as they can bind by “semi-
intercalation” in which partial insertion between base pair steps 
results in considerable bending of the duplex. [21-24] Furthermore, a 
structure obtained from a racemic mixture of 1 reveals that its 
enantiomers possess subtle differences in their intercalation 
geometries. [25] 
The optical properties of these systems are particularly attractive 
as, since intercalation results in large hypochromicity in the 
absorption bands of the complex, DNA binding can be monitored 
using UV-Visible spectroscopy. The luminescent properties of most 
Ru(dppz) complexes offer an even more facile means of monitoring 
binding: although their Rudppz 3MLCT-based emission is 
quenched in water, binding to DNA enhances luminescence by 
several orders of magnitude – a phenomenon that has become 
known as the DNA “light switch” effect.  
 
Figure 1. Mononuclear RuII(dppz) complexes relevant  to this report. 
Complex 1 and its derivatives are synthesized as racemic 
mixtures. Although the Λ and Δ enantiomers can be resolved via 
classical or chromatographic procedures, and they do show 
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differences in their binding properties and emission lifetimes, the Δ-
form shows only modest overall enantioselective DNA binding over 
its Λ-analogue.[15] Furthermore, the resolved RuII center in such 
complexes is coordinately saturated and attempts to modulate their 
binding properties using ancillary ligands often involves challenging 
chromatographic separation procedures, or non-trivial modification 
of already coordinated ligands. [12]   
To address both these issues, we have been investigating the 
properties of achiral [Ru(tpm)(L)(dppz)]n+ complexes (tpm = tris(1-
pyrazolyl)methane, L = chloride, N-donor ligand, n =1, 2), which 
contain an easily modulated coordination site. Using 2 as a 
precursor, complexes 3 and 4 – Fig 1 - were initially synthesized. 
The DNA binding parameters of these latter two complexes 
compare favourably with those of 1 and it was also found that 
complex 4 has a binding preference for GC sequences of DNA. [26] 
Using the same building block, bimetallic systems have been 
investigated. 
From first principles, ditopic substrates should bind more 
extended DNA sequences compared to similar mononuclear 
systems[27,28] and indeed the number of studies investigating the 
DNA binding and biological properties of oligonuclear metal 
complexes is rapidly growing.[29-37] Of particular relevance to this 
report, Keene and Collins have shown that dinuclear RuII complexes 
that bind nucleic acids through groove binding offer considerable 
potential as therapeutic leads. [38-42] 
Nevertheless, due to the synthetic difficulties discussed above, 
bisintercalating systems incorporating Ru units are still relatively 
rare. [43-45] The best-characterized systems are those reported by 
Lincoln, at al., in which bridging ligands containing linked dppz 
units have been used to create threading intercalators. [46-50] Due to 
the threading mechanism, [51] the resulting dinuclear complexes 
show extremely high binding affinities (in the nanomolar range) [52] 
and a binding preference for AT rich sequences. [50,53] On the other 
hand, the multi-step syntheses of these complexes starting from 
classically resolved chiral metal complex starting materials are not 
trivial. 
In contrast, using complex 2 as a starting point, we have shown 
that dinuclear systems incorporating [Ru(tpm)(dppz)]2+ moieties 
linked by a ditopic dipyridyl ligands can be readily prepared in two 
steps using the intermediate complex 5.  This approach provided a 
simple route to homo and – for the first time - heterometallic 
M(dppz) systems such as 6 and 7 – Scheme 1. [54-56] Disappointingly, 
although these systems bind to extended sequences and display 
unique photophysical properties, they do not show enhanced DNA-
binding compared to their analogous monometallic analogues. A 
possible reason for this observation involves the nature of the tether 
employed: isothermal calorimetric studies on 6 indicated that the 
favourable binding entropy for the tethered dinuclear system is 
lower than expected which was attributed to loss in the degrees of 
freedom available to the bound linker. 
In related studies, we found that the DNA binding affinities of 
mononuclear Ru(tpm)(pyNH2)(dppz)]n+   complexes (where pyNH2 
= 3- or 4-amino pyridine) are greatly affected by the positioning of 
substituents on the pyridine ligand. Although the 3-pyNH2-based 
complex binds by intercalation with affinities that are comparable to 
the parent compound, the coordinated 4-pyNH2 complex is a low 
affinity, non-intercalating, groove binder. NMR studies revealed that 
this is due to unfavourable interactions made by the 4-NH2 of the 
coordinated pyridine projecting into the minor groove of the 
duplex.[57,58] This suggests that 4-py-based connectivity within the 
tether of 6 may have an unfavourable effect on its binding 
characteristics. 
 
Scheme 1. Previously studied dinuclear complexes incorporating the RuII(tpm)(dppz) 
moiety synthesized from mononuclear complex 5. 
Therefore, with the long term aim of optimizing the DNA-
binding properties of oligonuclear [Ru(tpm)(dppz)]2+ complexes and 
ascertaining how the nature of the tether affects binding properties, 
we have prepared four connecting ligands that possess potential 
DNA recognition sites in themselves. The ligands, which have also 
been chosen to investigate the effects of changes in connectivity and 
linker rigidity on the binding properties of metallo-intercalators, 
have then been used to synthesize four new mononuclear and four 
new dinuclear complexes. The duplex DNA binding properties of 
these new complexes were then parameterised and compared to each 
other and their mononuclear analogues using a variety of 
biophysical techniques.   
Results and Discussion 
Synthetic studies.  The four new pyridine-based bridging ligands 
were prepared in high yield by reduction of the corresponding Schiff 
base ligands with NaBH4. The py-X-py linkers were prepared in a 
one-pot reaction in ethanol, whilst linkers py-Y-py were prepared in 
two steps through the condensation of benzene-1,4-
dicarboxaldehyde and the appropriate (aminomethyl)pyridine 
yielding a Schiff base which was reduced with NaBH4 in ethanol to 
afford the desired linker. 
Monomer RuII complexes were then obtained by first removing 
the chlorido ligand of [(tpm)Ru(dppz)(Cl)]PF6 using Ag+ and then 
adding an excess of the required dipyridyl linker ligand. Using this 
N N
n+
6, n = 4; M =
N
N N
N
N
N
N
NN
N
H
Ru
N N
2+
5
N
N N
N
N
N
N
NN
N
H
Ru
H
N
N
N
NN
N
Ru
N
N
N
N
M
7, n = 3; M =
OC
CO
OC
Re
N
N
N
N
 3 
method, complexes 8, and 10 incorporating the tether ligands N,N’-
bis(4-pyridylmethyl)-1,6-hexanediamine (4py-X-4py) and N,N'-
bis(4-pyridylmethyl)-1,4-benzenedimethyleneamine (4py-Y-4py), 
were obtained. Using isomeric tethers N,N’-bis(3-pyridylmethyl)-
1,6-hexanediamine (3py-X-3py) and N,N'-bis(3-pyridylmethyl)-1,4-
benzenedimethyleneamine (3py-Y-3py) complexes 12, and 14 were 
isolated through similar methods – Figure 2. All four tethers possess 
amino groups within their linker unit as this mimics the recognition 
motif of polyamines such as spermine and spermidine that bind non-
specifically - but with high affinity - to nucleic acids through 
electrostatic interactions.[59] 
 
Figure 2. New ditopic ligands, mono-, and dinuclear Ru(dppz) complexes reported in 
this study. 
Using the same methods outlined in Scheme 1, the mononuclear 
complexes were then used to synthesize analogous dinuclear 
systems [{Ru(tpm)(dppz)}2(4py-X-4py)]4+ (9), 
[{Ru(tpm)(dppz)}2(ȝ-4py-Y-4py)]4+ (11), [{Ru(tpm)(dppz)}2(3py-
X-3py)]4+ (13), and [{Ru(tpm)(dppz)}2(3py-Y-3py)]4+ (15) - Fig 2. 
Analytically pure dinuclear complexes could then be obtained 
through ion-exchange chromatography. 
Photophysical studies. The photophysical properties of 8 - 15 
as hexafluorophosphate salts in acetonitrile are summarized in Table 
1. The UV−Visible spectra of the complexes are dominated by high-
energy bands between 270−300 nm which correspond to π→π* 
transitions of the aromatic nitrogen donor ligands. The UV−Visible 
spectrum of the dppz ligand in acetonitrile exhibits a moderately 
intense band in the near-UV with two principal maxima at  = 358 
and 376 nm, which are characteristic of π→π*(dppz) transitions. [60] 
Consequently, the moderately intense bands in the near-UV regions 
for complexes 8 (351 nm), 9 (353 and 401 nm), 10 (352 nm) and 11 
(355 and 407 nm) are assigned to analogous transitions. 
The MLCT Ru(dπ)→dppz(π*) 1MLCT bands for 8−15 all 
appear in the region of the spectrum typical for ruthenium(II) 
complexes with coordinated polyimine ligands, although the 
dinuclear complexes are slightly red shifted by 20 - 30 nm compared 
to their corresponding mononuclear systems. Excitation into the 
MLCT band of the complexes results in the characteristic broad and 
unstructured emission originating from the Ru(dπ)→dppz(π*) 
3MLCT manifold, see Table 1. Depending on the complex, the 
energy of this emission ranged from around em = 635 - 661 nm. 
DNA Binding Studies. 
Water-soluble chloride salts of all eight complexes were 
obtained via anion metathesis of their respective PF6- salts using 
[nBu4N]Cl in acetone. Their interaction with CT-DNA in aqueous 
buffer (25 mM NaCl, 5 mmol tris, pH 7.4) was then investigated 
using UV–visible and emission spectroscopic titrations. 
Table 1. Room temperature photophysical properties of 8 − 15 as hexafluorophosphate 
salts in acetonitrile. 
 Absorption Emission 
Complex Λ / nm (10−3İ / ε−1 cm−1) Ȝex / nm Ȝem / nm 
Mononuclear complexes 
8 278 (55.4), 317 (19.5), 351  (20.3), 
401 (8.3), 431 (6.5), 494 (2.8) 
 
420 
 
661 
10 278 (55.4), 317 (20.0), 350 (21.1), 
401 (8.9), 431 (6.9), 491 (3.1) 
 
430 
 
659 
12 232 (22.0), 278 (38.5), 319 (10.7), 
357  (13.1), 401 (5.9), 441 (3.6), 501 
(1.6) 
440 644 
14 226 (24.7), 278 (30.9), 319 (14.4), 
355 (12.7), 401 (6.8), 435 (3.8), 496 
(1.5) 
430 639 
Dinuclear Complexes 
9 276 (100.3), 318 (29.6), 355 (25.9), 
368 (23.0), 468 (7.7) 
 
440 
 
630 
11 278 (59.4), 317 (20.5), 351 (21.2), 
401(8.9), 431(6.0), 494(3.3) 
 
460 
 
661 
13 227 (20.6), 279 (47.3), 319 (13.2), 
359 (18.2), 403 (8.1), 433 (5.6), 498 
(2.2) 
433 642 
15 229 (31.2), 278 (67.5), 317 (19.4), 
357 (19.8), 411 (9.5), 501 (3.7) 
417 635 
 
Optically based titrations. On addition of CT-DNA both the 
absorption and emission spectra of the complexes produced changes 
that are characteristic of DNA binding. Large hypochromicity in 
both π→π* and MLCT absorption bands are observed, Fig 3a, such 
shifts are often ascribed to an intercalative binding mode.  As 
expected, although all the complexes are essentially non-
luminescent in aqueous solutions, on addition of DNA, their 
RuIIdppz based 3MLCT emission is greatly enhanced – Fig 3b.  
This change is similar in magnitude for all the complexes, with 
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emission enhancements of x90 – 100 being observed. Since the 
mono- and dinuclear complexes display almost identical light switch 
effects on binding to DNA, it seems each Ru(dppz) unit of the 
dinuclear complexes is isolated from bulk solvent to the same extent 
as their corresponding mononuclear complex. Thus, it is tempting to 
conclude that the dinuclear complexes bis-intercalate into DNA, 
however a number of previous studies have shown that full 
intercalation is not always required for a light-switch effect to 
operate. [61-64] 
 
Figure 3. Details in changes in the UV-visible (A) and luminescence (B) spectra of 15 
ȝε complex 9 on progressive addition of CT-DNA in 5 mM tris buffer, 25 mM NaCl, 
pH 7.4 at 25 °C. 
Unfortunately, whilst both the absorption and emission data 
produce what appear to be typical binding curves, fits of either sets 
of titrations to the much-used McGhee-von Hippel model[65] for a 
single non-cooperative binding mode to the data were poorly 
correlated, suggesting more complex binding behaviour, possibly as 
a result of the heterogeneity of the binding sites on CT-DNA. 
Nevertheless, the UV-visible spectroscopic titrations could be 
analysed in terms of the multiple independent binding sites, MIS, 
model.  Our version of the MIS model [66] explicitly takes the ligand 
concentration into account – see SI for details - and thus avoids the 
need to keep the ligand concentration constant upon addition of 
DNA. As Figure 4 shows, the MIS model reproduces the data very 
well, despite the sequence heterogeneity of the CT-DNA used. 
Again, it should be noted that this does not necessarily indicate a 
single class of binding sites, as we have observed similarly good fits 
of the MIS model to nucleic acid binders, which actually display 
multiple binding modes when studied by ITC. [66] Therefore the 
quality of the observed fit cannot be used to conclude that binding is 
to a single class of sites. Taking this caveat in mind, we report 
apparent binding parameters in Table 2. This analysis also results in 
apparent binding sites with an average size of 2.2±1.0 base pairs.  
 
 
 
 
 
 
 
 
Figure 4. Examples of fits of the MIS model to the UV-Visible spectroscopic titration 
data. Top: complex 8, bottom: complex 9. In both cases:  • = data,  = fit  
Table 2. Apparent binding parameters from fitting the MIS model to UV-visible data for 
8-15 interacting with CT-DNA at 25 °C in 5 mM Tris, 25 mM NaCl, pH 7.4 
complex 
K 
 / 106 M-1 
binding site 
 / b.p. 
ε 
 
/ 103 M-1cm-1 
Δε 
 
 / 104 M-1cm-1 
λ 
/ nm 
Mononuclear complexes 
8  2.2±0.7 2.1±0.1 54.8 -3.19 278 
10  0.7±0.3 1.9±0.2 51.8 -3.05 276 
12  0.12±0.05 1.1±0.3 38.2 -2.58 280 
14  6.9±3.4 1.9±0.1 52.2 -2.65 280 
Dinuclear complexes 
9  0.9±0.3 2.4±0.2 64.3 -3.77 279 
11  0.2±0.1 1.1±0.3 45.1 -2.71 279 
13  1.7±0.6 4.6±0.3 75.1 -7.1a 268 
15  2.5±0.8 2.1±0.1 66.9 -3.59 278 
a) Δε restricted to values lower than ε. 
Despite the good fits and the typically reasonable binding site 
sizes, the MIS model may not be a complete model for the 
interactions between 8-15 and CT-DNA. For example, its sequence 
heterogeneity means that CT-DNA may contain a number of 
binding sites for which the studied complexes display a range of 
affinities. In addition, non-specific electrostatic interactions may 
further affect the spectroscopic data.[68] Therefore estimates from 
fits to this model probably define the lower limit of DNA binding 
affinities. Despite this limitation, these estimates reveal some 
striking trends. Although the apparent Kb values for the dinuclear 
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78
nm
[DNA]/mol dm-3
0.0 4.0x10-5 8.0x10-5 1.2x10-4
0.4
0.6
0.8
1.0
A 2
79
nm
[DNA]/mol dm-3
 5 
complexes still appear to be comparable or slightly lower to their 
corresponding mononuclear complexes, it is clear that the nature of 
the tether does affect the binding properties of the complexes, with 
complexes 14 and 15 - which both contain the py-Y-py linker - 
displaying affinities that are up to an order of magnitude larger than 
complexes 5 – 13. Viscosity studies were used to explore this issue 
in more detail.  
Viscosity Studies. Viscosity measurements provide a 
convenient method to confirm DNA binding modes. In particular, 
intercalation leads to a lengthening of DNA, thus producing an 
easily detected concomitant increase in the relative viscosity of 
DNA solutions, while groove binding does not cause such effects. 
[67-69]
 Viscosity experiments on 8 – 15 (Figure 5) revealed distinctive 
variance between complexes with different ligand connectivity. 
 
Figure 5. Relative viscosity changes in CT-DNA solutions on addition of (A) complexes 
8 – 11 and (B) complexes 9 – 15.  For ease of comparison changes induced by the 
groove binder H33258 and intercalator EtBr under the same conditions are also 
included. 
Although additions of 4-py complexes 8 – 11 to CT-DNA 
solutions produce a positive increase in viscosity, their effect is 
smaller than that of the confirmed, nonspecific, intercalator ethidium 
bromide, EtBr. Furthermore, comparisons between the complexes 
show that the dinuclear complexes produce less change in viscosity 
than their corresponding mononuclear analogues; it is also apparent 
that complexes 10 and 11, which incorporate the less flexible 4py-
Y-4py tether, induce less change than the 4py-X-4py-based 
complexes 8 and 9 - Fig 5a. 
In contrast, additions of 3-py complexes 12 – 15 induce 
viscosity changes that are significantly larger than those induced by 
EtBr and although mononuclear complex 12 induces a larger 
increase than its dinuclear analogue 13, a comparison between the 
two complexes coordinated to the more rigid 3py-Y-3py tether 
shows that dinuclear complex 15 now actually induces larger 
changes than mononuclear complex 14 – Fig 5b. 
These observations suggest that, due to reduced unfavourable 
steric interactions of 3-py complexes with the duplex, complexes 12 
- 15 are deeper, more effective intercalators than 8 – 11; however 
the possibility that the latter systems are more selective and bind at 
specific sites within a sequence cannot be discounted as this would 
also produce a lower overall lengthening of the DNA. Nevertheless, 
again, it is clear that the nature of the linker has a profound effect on 
the DNA interactions of these new complexes. To parameterize 
these effects in more detail isothermal calorimetry, ITC, 
experiments were carried out.  
Isothermal calorimetry studies. For all the new complexes 
binding thermodynamics with DNA at 25 °C were determined by 
ITC. First, the heat effects for dilution were determined (not shown) 
and these were found to be constant, an observation that indicates 
that 8-15 do not aggregate significantly under the experimental 
conditions; consequently, titrations with CT- DNA were then carried 
out. 
 
Figure 6. Enthalpograms for the interaction of 10, 11, 14 and 15 with CT-DNA at 25 °C 
in 5 mM Tris, 25 mM NaCl, pH 7.4. 
As shown in Figure 6, several of the titrations exhibit non-
constant heat effects before a main sigmoidal transition around a 
molar ratio of 0.3 corresponding to saturation of binding sites. These 
non-constant heat effects are typical of multiple simultaneous 
equilibria in which binding affinities are very close in magnitude.[70] 
Again, the presence of such binding sites is not surprising 
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considering the heterogeneity of the CT-DNA sequence and is broad 
agreement with the data derived from UV-visible titrations (vide 
supra). The binding isotherm for 15, however, shows two clear 
sigmoidal transitions, one around a molar ratio of 0.3 and one 
around a molar ratio of 0.6. These transitions are clearly indicative 
of two binding events with well-defined and significantly different 
binding affinities. 
Figure 6 also shows that the observed heat effects are generally 
rather small, which is not uncommon for binding events involving a 
significant contribution from hydrophobic interactions.[71] DNA 
binding of 8 - 10 and 12 - 14 is slightly endothermic but the 
interaction of 11 with CT-DNA is strongly exothermic, while the 
interaction of 15 with CT-DNA displays an exothermic event as 
well. 
To obtain binding parameters, and evaluate the significance of 
the obtained values, the enthalpograms were analysed using the in-
house software packages ICITC and I2CITC.[72,73] Typically, 
statistically significant values could only be determined for the main 
transitions, i.e. the binding events with stoichiometries around 0.3, 
and these are summarized in Tables 3 and 4. 
Table 3. Summary of binding parameters for the main binding mode of 4-py-based 
complexes 8 – 11 interacting with CT-DNA at 25 °C in 5 mM Tris, 25 mM NaCl, pH 
7.4 from ITC. 
Complex 8 9 10 11 
equilibria in 
fit 
1 2[a] 2[a] 1 
Kb / M-1 6.4 × 105 1.6 × 105 1.5 × 105 1.0 × 105 
S / bp 3.7 2.8 2.8 2.4 
∆H / kJ mol-1 10.8 8.2 6.4 -39.4 
-T∆S / kJ mol-
1
 
-43.9 -32.5 -35.8 +11 
∆G / kJ mol-1 -33.1 -29.7 -29.4 -28.4 
[a] n for the first equilibrium was restricted to the range [0.0002 – 0.2] ligands per base 
pair, i.e. S was restricted to the range [5-5000] base pairs. 
Table 3 shows the thermodynamic parameters for binding of the 
first group of complexes, 8 – 11, involving 4-py linkages. These 
data do not allow quantification of the binding parameters for the 
first binding events for 9 and 10 because of extensive parameter 
correlation. This inability to unambiguously quantify the first 
binding events is expected, as the enthalpograms do not display a 
clear sigmoidal transition from one binding event to the next. 
The quantified interactions of 8 – 10 display a very similar 
thermodynamic signature, as they are all slightly endothermic with 
entropy driven binding. Strikingly, as is already obvious from the 
form of the enthalpograms, dinuclear complex 11 shows a very 
different thermodynamic profile, with binding being enthalpy driven 
and entropy opposed. Within this group, binding constants for the 
dominant mode for the dinuclear complexes is lower than that for 
the corresponding monomeric complex, while the binding site size 
remains more or less constant. The interaction parameters thus 
indicate that the affinities of the dinuclear complexes are not 
increased through multivalency. Moreover, it is clear that in both 
cases the reduced affinity of the bisintercalator is due to a lower 
favourable entropic contribution to binding. These observations are 
consistent with our previous ITC studies on complexes 5 and 6. 
Table 4. Summary of binding parameters for 3-py-based complexes 12 – 15 interacting 
with CT-DNA at 25 °C in 5 mM Tris, 25 mM NaCl, pH 7.4 from ITC. 
Complex 12 13 14 15 
equilibria in fit 2 1 2 2 
Kb1 / M-1 -[a] 1.9 × 105 -[a] 2.7 × 107 
S1 / bp -[a] 2.1 -[a] 3.3 
∆H1 / kJ mol-1 -[a] 4.0 -[a] 0.6 
-T∆S1 / kJ mol-1 -[a] -34.1 -[a] -43.1 
∆G1 / kJ mol-1 -[a] -30.1 -[a] -42.5 
Kb2 / M-1 1.2 × 105  3.8 × 105 3.5 × 105 
S2 / bp 2.5  2.7 3.5 
∆H2 / kJ mol-1 7.3  5.1 -2.8 
-T∆S2 / kJ mol-1 -36.3  -37.0 -29.0 
∆G2 / kJ mol-1 -29.0  -31.9 -31.8 
[a] not quantifiable based on the available calorimetric data. 
The data in Table 4 indicate that - in contrast to their 4-py linked 
analogues - the 3-py-linked dinuclear complexes display similar or 
higher affinities for DNA than their corresponding mononuclear 
complexes, with the estimated Kb for first binding phase for 15 is 
around two orders of magnitude larger than estimates obtained for 5 
and 6 using the same technique.[55] A comparison of the available 
data for 14 and 15 also reveals striking differences: both binding 
phases of the dinuclear complex display a more favourable entropy 
change and a decreased endothermic contribution compared to the 
data for the mononuclear analogue, indeed the second binding event 
between 15 and CT-DNA is actually exothermic. Further analysis of 
this data is revealing. 
Using enthalpy-entropy compensation plots, Chaires has shown 
that groove binders and intercalators DNA have distinctive 
thermodynamic signatures.[74,75] A similar analysis involving the 
ITC data shown in Tables 3 and 4 is presented in Figure 7. The data 
for 8 – 15 are compared to the ITC parameters obtained by Collins 
and Keene[40] in studies on the minor groove binding complexes 
shown in the figure.  
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Figure 7. Compensation plot comparing the thermodynamic signatures of complexes 8 – 
15 with those of purely minor groove binding complexes reported by Collins and Keene. 
In these plots, the two series of complexes can be partitioned 
into three areas. Unsurprisingly, the purely groove binding 
complexes reported by Collins and Keene are found in the upper left 
quadrant, as this interaction is known to be entropically favoured 
and enthalpically opposed. Sitting in the bottom right quadrant of 
the plot, the thermodynamic data for 11 is uniquely different as it 
shows a strongly entropically opposed but enthalpically favoured 
interaction. This signature is almost identical to a pure intercalator 
such as ethidium bromide, indicating that there is no binding 
contribution from the potentially groove binding 4py-Y-4py linker. 
This is at odds with the observation that 11 produces the smallest 
increase in the relative viscosity of DNA solutions. As discussed 
previously these seemingly contradictory observations could be 
suggestive of a more selective interaction with binding only 
occurring at specific sites within a sequence. An alternative 
explanation is that the amino groups of the tether are making 
specific contacts within a groove, as hydrogen bonding possesses 
the same observed thermodynamic profile.   
Finally, the parameterized binding modes of complexes 8  - 10 
and 12 – 15 all display favourable entropies but relatively small 
enthalpy terms, leading to either slightly endothermic or exothermic 
interactions; observations that are clearly consistent with mixed, 
groove binding/intercalative, interactions.  
Conclusion 
Although the apparent binding parameters derived from the UV-
visible titration must be considered with some care, taken together 
with the viscosity and ITC analysis, it is clear that the nature and the 
connectivity of the ligand tether has significant effects on the quality 
and intensity of binding within this series of newly synthesized 
complexes. In particular, ITC - which makes the availability of 
multiple different binding sites more obvious and thus allows more 
direct quantification of the strength of individual interactions - 
clearly identifies 15 as the most tightly binding system, binding 
DNA with the highest affinity for a non-threading bis-intercalating 
metal complex. The ITC data also shows that complex 11 is unique 
in this series of compounds, as it has an entirely enthalpically driven 
binding profile, typically seen in “pure” intercalators. Furthermore, 
all the biophysical studies highlight that the 3py based linkers 
display enhanced binding compared to their 4py analogues, whilst 
the ITC data suggests that, in particular, the more rigid and 
hydrophobic 3py-Y-3py linker contributes favourably to the 
observed interactions. 
These findings show that by optimising linker design for tpm-
Ru-based bisintercalators, thermodynamic profiles can be 
profoundly affected and overall binding affinities significantly 
enhanced. In particular, the anchor point of pyridine-based tether 
ligands and the incorporation of recognition sites and/or rigidity 
within the linker moiety can be used to improve overall affinities. 
By exploiting this design principle, related architectures with further 
enhanced binding affinities, as well as new photochemical 
properties, can be readily synthesized. Future studies will also 
investigate any differences in the binding selectivities of 8 – 15 and 
their analogues. 
Experimental Section 
Materials. Solvents were dried and purified using standard literature methods, while 
other commercially available materials were used as received. [(tpm)Ru(dppz)Cl]PF6, 
(2) was prepared as described previously.1e,8 The buffer used for UV−visible titrations 
consisted of 25 mM NaCl and 5 mM tris (pH 7.0) prepared with doubly distilled water 
(Millipore). Calf thymus DNA (CT-DNA) was purchased from Sigma and was 
sonicated for 15 minutes and subsequently purified until A260/A280> 1.9. Concentrations 
of CT-DNA solutions in terms of concentrations of base pairs were determined 
spectroscopically using the extinction coefficient of CT-DNA (İ = 13200 dm3 mol−1 
cm−1 at 260 nm). 
Instrumentation. 1H NMR spectra were recorded on a Bruker AV2-400 machine. ES 
mass spectra were obtained on a Micromass LCT ES-TOF machine, working in positive 
ion mode, with m-nitrobenzyl alcohol matrix. UV-visible spectra were recorded on a 
thermo regulated Varian-Carey 50 UV-Visible spectrometer at 25°C. Spectra were 
recorded in matched quartz cells and were baseline corrected. Steady-state 
luminescence emission spectra were recorded either in aerated acetonitrile or tris buffer 
solutions on a thermo regulated Horiba Jobin-Yvon FluoroMax-3 spectrophotometer. 
All ITC experiments were carried out using a Microcal VP ITC microcalorimeter. Raw 
ITC data (see Supporting Information) were visualised using Microcal PEAQ-ITC 
Analysis Software 1.0.0.1259 (Malvern Instruments Ltd.). 
Methods. DNA viscosity experiments were carried out using published procedures. 
UV-visible titrations were carried out in a small volume (1000 ȝL) 1 cm path-length 
quartz cuvette. For every data point, 2.5 ȝL of the solution in the cuvette was replaced 
by 2.5 ȝL of a DNA stock solution. The DNA stock solution was 2.82 mM (in base 
pairs) for the titrations for complexes 8 - 13 and 1.0 mM (in basepairs) for the titrations 
for complexes 14 and 15. This procedure was carried out twice, once for a solution of 
the ligand and once for buffer only. The spectra for DNA in buffer were subsequently 
subtracted from the spectra for the solutions containing both complex and DNA to 
obtain the corrected spectra as shown in Figure 3 and Figures S1-7. The highest 
absorbances before subtraction of the spectra for DNA only did not exceed 2, ensuring 
that the data were recorded in the range of absorbances were the instrument response is 
linear. Titration curves at appropriate wavelengths were extracted from the corrected 
full spectra. The MIS model was fit to the titration curves using Origin 9.0.0 (64 bit) 
SR2 (OriginLab Corporation). All ITC experiments were carried out at 25 °C. Complex 
solutions were prepared in tris buffer (5 mM Tris, 25 mM NaCl, pH 7.4) and 
concentrations were determined using UV-visible spectroscopy based on extinction 
coefficients. The sample cell and syringe were always cleaned with ethanol followed by 
further cleaning with distilled water before starting any experiment. The sample cell 
was filled with FS-DNA solution (approximately 1.9 ml). The syringe was filled with 
ligand solution (approximately 300 µl) with a concentration usually 4 fold higher than 
DNA solution (exact ratios depend on individual experiments). The ligand solution was 
added to the sample cell in 1 injection of 5 µl for the first addition followed by 19 
injections of 15 µl each, automatically injecting every 300 seconds. During the titrations 
the solutions in the sample cell mixed at a stirring speed of 311 rpm. The heat effects 
per injection (dh) were calculated using Origin (Microcal, Inc). integrated heat effects 
were analysed using IC ITC and I2CITC. During the fitting routines, parameter values 
were restricted to the ranges below to avoid spurious numerical problems caused by 
unphysical parameter values, unless otherwise noted. Enthalpies are restricted to the 
range [-5×105 – +5×105] cal mol-1; equilibrium constants are restricted to the range [1 – 
6×1020] M-1 with the second equilibrium constant restricted to values smaller than the 
first equilibrium constant to avoid swap-overs; the stoichiometries were restricted to the 
range [0.0002 – 20] molecules per macromolecule unit (here base pairs). 
Syntheses 
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N,N’-bis(4-pyridylmethyl)-1,6-hexanediamine (4py-X-4py). A solution of 4-
pyridinecarboxaldehyde (18.5 g, 173 mmol) in ethanol (100 mL) was added to a 
solution of 1,6-hexanediamine (10.0 g, 86.6 mmol) in ethanol (200 mL) and then heated 
to reflux for 2 h. The reaction solution was allowed to cool to room temperature. NaBH4 
(8.0 g, 211 mmol) was carefully added in small portions and then the mixture was 
heated to reflux for 2 h and then stirred at room temperature overnight. Aqueous NaOH 
(2.0 M, 2 00 mL) was added to the solution. The aqueous solution was extracted with 
CH2Cl2 (3 × 200 mL), the organic fractions combined and dried over anhydrous MgSO4. 
Filtration and concentration under reduced pressure yielded pale coloured viscous oil. 
On shaking with diethyl ether a cream coloured solid precipitated, which was collected 
by filtration, washed with copious amounts of diethyl ether and dried in vacuo (20.2 g, 
74%).  1H NMR (400 MHz, CDCl3): įH = 8.49 (dd, J = 8.0, 2.8 Hz, 4H), 7.50 (d, J = 8.0 
Hz, 4H), 3.82 (s, 4H), 2.64 (t, J = 6.72 Hz, 4H), 1.81 (t, J = 8.4 Hz, 4H), 1.45(m, 4H). 
13C NMR (63 MHz, CDCl3)μ į 27.1, 30.0, 4λ.4, 52.7, 122.λ, 14λ.6, 14λ.8; ES-MS m/z = 
299 (MH+). 
N,N’-bis(3-pyridylmethyl)-1,6-hexanediamine (3py-X-3py) was prepared in an 
identical manner to that above, except the 3-pyridinecarboxaldehyde was used in place 
of 4-pyridinecarboxaldehyde. (84.9 %); 1H NMR (400 MHz, CDCl3): įH = 8.49 (s, 2H), 
8.33 (d, J = 6.0 Hz, 2H), 7.38 (m, 2H), 6.99 (m, 2H), 4.42 (s, 4H), 2.79 (m, 4H), 2.05 (s, 
2H), 1.51 (m, 4H), 1.07 (m, 4H), ES-MS m/z = 299 (MH+). 
N,N'-bis(4-pyridylmethyl)-1,4-benzenedimethyleneamine (4py-Y-4py). Benzene-
1,4-dicarboxaldehyde (5.0 g, 27.3 mmol) and 4-(aminomethyl)pyridine (8.06 g, 74.6 
mmol) were placed in CH2Cl2 (100 mL). Anhydrous MgSO4 (20 g) was added to the 
solution and the mixture was stirred at room temperature for 24 h. The mixture was 
filtered and the filtrate concentrated under reduced pressure yielding the Schiff base as a 
golden coloured viscous oil which was not isolated. The oil was taken up in ethanol 
(150 mL) and NaBH4 (4.0 g, 106 mmol) was added in small portions. After heating this 
mixture to reflux for 2 hours, it was then stirred at room temperature overnight and then 
aqueous NaOH (2.0 M, 200 mL) was added to the solution. The aqueous solution was 
extracted with CH2Cl2 (3×100 mL), the organic fractions combined and dried over 
anhydrous MgSO4. Filtration and concentration under reduced pressure yielded the 
product as a golden coloured viscous oil which solidified into a waxy solid (9.5 g, 80%). 
1H NMR (400 MHz, CDCl3): įH  = 8.47 (dd, J = 6.2, 2.8 Hz, 4H), 7.28–7.22 (m,8H), 
3.78 (s, 4H), 3.72 (s, 4H); 13C NMR (63 MHz, CDCl3)μ į 51.8, 52.9, 123.0, 128.3, 138.7, 
149.4, 149.8; ES-MS m/z = 318 (MH+). 
N,N'-bis(3-pyridylmethyl)-1,4-benzenedimethyleneamine (3py-Y-3py) was prepared 
in an identical manner to that above, except the 3-(aminomethyl)pyridine was used in 
place of 4-(aminomethyl)pyridine. (80%); 1H NMR (400 MHz, CDCl3): įH = 8.52 (s, 
2H), 8.35 (d, J = 6.0 Hz, 2H), 7.76 (d, J = 8.0 Hz 2H), 7.49 (m, 2H), 7.30 (s, 4H), 3.85 
(s, 4H), 3.80 (s, 4H), ES-MS m/z = 319 (MH+). 
Synthesis of mononuclear complexes 
Mononuclear complexes 8, 10, 12, and 14 were prepared in an identical manner to that 
reported previously for 510 but replacing the original linker ligand with 4py-X-4py, 4py-
Y-4py, 3py-X-3py, or 3py-Y-3py, respectively.  
[Ru(tpm)(dppz)(4py-X-4py)][PF6]2 (8). Orange colored solid (75%); 1H NMR (400 
MHz, d6-acetone):  įH = 9.84 (d, J = 8.2 Hz, 2H), 9.17 – 9.03 (m, 2H), 8.76 (s, 1H), 
8.51 (m, 2H), 8.37 (t, J = 11.3 Hz, 2H), 8.23 (dd, J = 6.5, 3.4 Hz, 2H), 8.07 (dd, J = 8.3, 
5.5 Hz, 4H), 7.59 – 7.40 (m, 2H), 7.27 – 7.01 (m, 4H), 6.94 – 6.76 (m, 2H), 6.46 (d, J = 
2.1 Hz, 1H), 6.33 – 6.16 (m, 2H), 4.14 (s, 2H), 4.05 (s, 2H), 2.99 (t, J = 10 Hz, 2H), 
2.94 (t, J = 5 Hz, 2H), 1.93 (m, 4H), 1.59(m, 4H); m/z (ES-MS) 1041 (100%, [M–PF6]+). 
(HRES-MS) 1041.2716 (100%, [M–PF6]+. C46H46N14F6PRu requires 1041.2715). 
Elemental analysis of chloride salt calcd (%) for C46H46Cl2N14Ru2H2O : C  55.04, H  
4.98, N  19.54; found: C  54.94; H  4.39; N  15.59; 
 
[Ru(tpm)(dppz)(4py-Y-4py)][PF6]2 (10). Orange colored solid (56%); 1H NMR (400 
MHz, d6-acetone): įH  = 9.84 (d, J = 7.1 Hz, 2H), 9.02 (dd, J = 6.6, 3.3 Hz, 2H), 8.86 (s, 
1H), 8.74 – 8.50 (m, 4H), 8.50 – 8.35 (m, 4H), 8.23 (dd, J = 6.5, 3.4 Hz, 4H), 8.12 – 
7.94 (m, 2H), 7.73 (dd, J = 3.7, 7.0 Hz, 4H), 7.60 (s, 4H), 7.58 – 7.31 (m, 4H), 6.84 (d, J 
= 2.4 Hz, 1H), 4.25 (m, 2H), 4.11 (s, 2H), 3.14 – 3.02 (m, 4H); m/z (ES-MS) 1061 
(100%, [M –PF6]+). HRES-MS: 1061.2435 (100%, [M –PF6]+. C48H42N14F6PRu requires 
1061.2402). Elemental analysis of chloride salt calcd (%) for C48H42Cl2N14RuH2O: C 
57.31, H 4.37, N 19.50; found: C  57.26; H  4.30; N  19.47; 
[Ru(tpm)(dppz)(3py-X-3py)][PF6]2 (12). Red-orange coloured solid (63.3 %); 1H 
NMR (400 MHz, CD3CN): įH = 10.06 (s, 1H), 9.81 (d, J = 8.2 Hz, 2H), 9.10 (d, J = 
5.5 Hz, 2H), 8.67 (d, J = 5.3 Hz, 2H), 8.48 (d, J = 2.8 Hz, 2H), 8.20 (m, 2H), 7.87 (m, 
2H), 7.82 (m, 2H), 7.48 (dd, J = 10 Hz, 4 Hz, 2H), 7.38 (m, 2H), 7.06 (dd, J = 4.4, 1.4 
Hz, 2H), 6.83 (t, J = 4 Hz, 2H). 6.79 (m, 2H), 6.44 (d, J = 2.2 Hz, 2H), 6.29 – 6.14 (m, 
1H), 4.34 (s, 2H), 3.53 (s, 2H), 2.98 (m, 2H), 1.97 (m, 2H), 1.50 (dt, J = 4.9, 2.5 Hz, 
4H), 1.36 (m, 4H);;  m/z (ES-MS) 1041 (100% [M-PF6]+). HRES-MS: 1041.2710 
(100% [M-PF6]+. C46H46N14F6PRu requires 1041.2726). calcd (%) for 
C46H46F12N14P2RuH2O: C 45.85, H  3.98,  N  16.28; found: C  45.62, H  3.81, N  16.57 
[Ru(tpm)(dppz)(3py-Y-3py)][PF6]2 (14). Orange coloured solid (65%); 1H NMR (400 
MHz, CD3CN): įH =  9.81 (d, J = 7.6 Hz, 2H), 9.13 (s,1H), 9.08 (d, J = 4.7 Hz, 2H), 
8.63  (t, J = 7.8 Hz, 2H), 8.60 (d, J = 2.4 Hz, 2H), 8.57 (m, 2H), 8.41 (d, J = 2.5 Hz, 2H), 
8.21 (m, 2H), 8.06 (d, J = 2.8 Hz, 2H), 7.85 (d, J = 8 Hz, 2H), 7.56 (m, 4H), 7.36 (d, J = 
6 Hz, 2H), 7.05 (t, J = 8 Hz, 2H), 6.80 (t, J = 2.3 Hz, 2H), 6.38 (d, J = 2.0 Hz, 2H), 6.17 
(t, J = 8.4 Hz, 1H)  2.60 (s, 2H), 2.55 (m, 2H), 1.59 (m, 2H), 1.52 (m, 2H);; m/z (ES-
MS) 1061 (100%, [M –PF6]+). HRES-MS: 1061.2397 (100%, [M –PF6]+. 
C48H42N14F6PRu requires 1061.2444). calcd (%) for C48H42F12N14P2Ru3H2O: C 45.71, 
H 3.80, N 15.55; found: C  45.69, H  3.69, N  15.42 
Synthesis of dinuclear complexes 
The dinuclear complexes were synthesised through a method adopted from that reported 
for complex 6, illustrated by the detailed procedure used for complex 9. Like many 
polyamines such as spermine derivatives these complexes are hygroscopic[76] so that 
rigorously dried samples rapidly absorb water, therefore consistent elemental analyses 
were only obtained through exposure to the atmosphere until weight changes no longer 
occurred. 
[{(tpm)Ru(dppz)}2(4py-X-4py)][(PF6)4] (9). [(tpm)Ru(dppz)(Cl)]PF6 (65 mg, 0.08 
mmol) and AgNO3 (120 mg, 0.70 mmol) were placed in a 1:1 mixture of ethanol and 
water (40 mL) and  heated to reflux for 2 h. The solution was allowed to cool and 
filtered through celite to remove the AgCl precipitate. The filtrate was returned to the 
reaction vessel. [8][(PF6)2] (360 mg, 0.3 mmol) in acetone (15 mL) was added and the 
solution was refluxed for 72 h. The solution was allowed to cool to room temperature. 
Purification was achieved via ion-exchange chromatography on Sephadex CM-25 resin 
eluting with water acetone mixtures (5:3) with increasing concentrations of NaCl. 
Monomeric complexes were eluted with 0.05 M NaCl and the desired bimetallic 
complex was eluted with 0.1–0.2 M NaCl in water:acetone (5:3). A concentrated 
aqueous solution of NH4PF6 (~10 mL) was added to the filtrate. On concentration in 
vacuo, the bimetallic complex precipitated. It was collected by centrifugation, washed 
with copious amounts of water and dried in vacuo producing the title compound in 48% 
yield.  Ȝmax(CH3CN)/nm  276 (İ/dm3 mol–1 cm–1 100 300), 318 (29 600), 355 (25 900), 
368 (23 000), 468 (7 700); 1H NMR (400 MHz, d6-acetone): įH  = 10.09 (s, 2H), 9.83 
(dd, J = 3.0, 2.3,Hz, 4H), 9.11 (dd, J = 1.3, 5.8 Hz, 4H), 8.97 (d, J = 2.4 Hz, 2H), 8.77 – 
8.49 (m, 4H), 8.38 (dd, J = 4.1, 2.9 Hz, 4H), 8.38 – 8.10 (m, 4H), 8.10 – 7.97 (m, 4H), 
7.66 – 7.42 (m, 6H), 7.09 (t, J = 6.3 Hz, 2H), 6.96 – 6.75 (m, 4H), 6.64 (d, J = 2.3 Hz, 
2H), 6.34 – 6.21 (m, 2H), 4.28 (s, 4H), 3.38 (m,4H), 1.82 (m, 8H), 1.58 (m, 4H); (ES-
MS) 892 (100%, [M –2PF6]2+). HRES-MS: 892.1607 (100%, [M –2PF6]2+. 
C74H66N24F12P2Ru2 requires 892.1636). calcd (%) for C74H66F24N24P4Ru23H2O : C 
41.74, H 3.38, N 15.79; found: C 41.22, H 3.45, N 15.86 
[{(tpm)Ru(dppz)}2(4py-Y-4py)][(PF6)4] (11) was prepared in an identical manner to 
that above, except  the monomeric complex [10][(PF6)2]  was used in place of 
[8][(PF6)2]. (45%) 1H NMR ( 400 MHz, d6-acetone): įH = 9.96 (s, 2H), 9.90 – 9.74 (m, 
4H), 9.64 (d, J = 8.1 Hz, 4H), 9.30 – 9.00 (m, 4H), 8.59 (dd, J = 3.7, 2.5 Hz, 4H), 8.39 (t, 
J = 2.3 Hz, 2H), 8.28 (d, J = 4.0 Hz, 4H), 8.19 – 7.99 (m, 4H), 7.68 (d, J = 3.3 Hz, 4H), 
7.44 (t, J = 2.1 Hz, 4H), 7.13 (d, J = 5.8 Hz, 4H), 7.13 – 6.92 (m, 4H), 6.87 – 6.57 (m, 
4H), 6.57 – 6.37 (m, 2H), 6.19 (t, J = 1.7 Hz, 2H), 4.06 (s, 4H), 3.30 (s,4H); HRES-MS: 
902.7491 (100%, [M –2PF6]2+. C76H62F12N24P2Ru2 requires 902.7462); elemental 
analysis of chloride calcd (%) for C76H62Cl4N24Ru26H2O : C  51.71, H  4.19, N  19.05; 
found: C  51.42, H  4.25, N  19.81; m/z (ES-MS) 901 (100%, [M –2PF6]2+). 
[{(tpm)Ru(dppz)}2(3py-X-3py)][(PF6)4] (13) was prepared in an identical manner to 
that above, except the monomeric complex [12][(PF6)2]  was used in place of [8][(PF6)2]. 
(60%). 1H NMR (400 MHz, CD3CN): įH =  9.83 (dd, J = 8.2, 1.2 Hz, 4H), 9.21 (s, 2H), 
9.10 (d, J = 5.6 Hz, 2H), 8.38 (d, J = 2.8 Hz, 4H), 8.27 (m, 6H), 8.12 (s, 2H), 8.02 (m, 
2H), 7.81 (dd, J = 9.9, 4.2 Hz, 8H), 7.67 (dd, J = 7.8, 6.0 Hz, 4H), 7.50 (m, 4H), 7.25 (t, 
J = 1.6 Hz, 2H), 6.86 (t, J = 4 Hz, 6H) 6.40 (m, 2H), 3.47 (s, 4H), 2.79 (m, 4H), 1.83 (m, 
4H), 1.76 (m, 4H); m/z (ES-MS) 892 (100%, [M –2PF6]2+). HRES-MS: 892.1636 
(100%, [M –2PF6]2+. C74H66N24F12P2Ru2 requires 892.1631). calcd (%) for 
C74H66F24N24P4Ru22H2O : C 42.09, H 3.31, N 15.92; found: C 42.60, H 3.39, N  15.31. 
[{(tpm)Ru(dppz)}2(3py-Y-3py)][(PF6)4] (15) was prepared in an identical manner to 
that above, except  the monomeric complex [14][(PF6)2]  was used in place of 
[8][(PF6)2]. (56 %): 1H NMR (400 MHz, CD3CN): įH =  9.79 (dd, J = 7.9, 2.5 Hz, 4H), 
9.21 (m, 2H), 9.10 (s, 2H), 8.64 (m, 4H), 8.53 (t, J = 4.9 Hz, 4H), 8.36 (t, J = 4.9 Hz, 
4H), 8.20 (s, 2H), 8.17 (m, 2H), 7.96 (m, 4H), 7.80 (m, 4H), 7.62 (d, J = 2.3 Hz, 4H), 
7.28 (m, 2H), 7.08 (s, 4H), 6.81 (m, 4H), 6.62 (d, J = 2.3 Hz, 4H) 6.28 (m, 2H) 2.97 (s, 
4H), 2.73 (m, 4H); m/z (ES-MS) 902 (100%, [M –2PF6]2+). HRES-MS: 902.1474 
(100%, [M –2PF6]2+. C76H62F12N24P2Ru2 requires 902.1511); elemental analysis calcd 
(%) for C76H62F12N24P4Ru26H2O : C  41.42, H  3.36, N  15.26; found: C 41.33, H 3.05, 
N 15.79. 
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